To further our understanding of progesterone (P) as an endocrine mammogen, a PR lacz knockin mouse was generated in which the endogenous progesterone receptor (PR) promoter directly regulated lacZ reporter expression. The PR lacz mouse revealed PR promoter activity was restricted to the epithelial compartment during the prenatal and postnatal stages of mammary gland development. At puberty, PR promoter activity was unexpectedly robust and restricted to the body cells within the terminal end buds and to the luminal epithelial cells in the subtending ducts. In the adult, the preferential localization of PR lacz positive cells to the distal regions of ductal side branches provided a cellular context to the recognized mandatory role of P in ductal sidebranching, and segregation of these cells from cells that undergo proliferation supported an intraepithelial paracrine mode of action for P in branching morphogenesis. Toward the end of pregnancy, the PR lacz mouse disclosed a progressive attenuation in PR promoter activity, supporting the postulate that the preparturient removal of the proliferative signal of P is a prerequisite for the emergence of a functional lactating mammary gland. The data suggest that PR expression before pregnancy is to ensure the specification and spatial organization of ductal and alveolar progenitor cell lineages, whereas abrogation of PR expression before lactation is required to enable terminal differentiation of the mammary gland. 
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M
OST OF THE physiological effects of progesterone (P) are mediated by its intracellular receptor, the progesterone receptor (PR), a member of the nuclear receptor superfamily of transcription factors (1, 2) . The PR is composed of two receptor isoforms: PR-A and -B, which have been shown to exhibit differential transactivational properties in vitro (3) and, more recently, in vivo (4) . Characterization of the PR knockout (PRKO) mouse (5) , in which both PR isoforms were simultaneously ablated by gene-targeting approaches, provided critical in vivo validation of this nuclear receptor's indispensable role in the normal development and function of the ovary, uterus, brain, and mammary gland. Although nonessential for organismic survival per se, the spectrum of phenotypes exhibited by the PRKO female reiterated the functional versatility of the PR in ensuring full reproductive capacity and the perpetuation of the species.
Among the wide range of PRKO reproductive phenotypes examined, the PRKO mammary defect, consisting of an impairment in pregnancy-associated tertiary ductal side-branching and alveologenesis, furnished much needed clarification with respect to the proliferative role of P in this tissue (6) . Noteworthy was the observation that removal of the mammotrophic effects of P resulted in a marked reduction in the susceptibility of the PRKO mouse to carcinogen-induced mammary tumorigenesis (7) , underscoring the complicity of this hormonal signaling pathway in facilitating the genesis and/or progression of this mammary tumor type. This finding also concurred with the conclusions of a number of recent clinical studies (8) (9) (10) , which reported that combined estrogen (E)-P postmenopausal hormone replacement therapies increased breast cancer risk beyond that observed for E treatment alone.
Considering the pivotal role of P in enabling mammary morphogenesis to proceed through a developmental cycle that incorporates the stages of pregnancy, lactation, and involution (11) , and because completion of this cycle early or late in reproductive life can attenuate or accentuate breast cancer risk, respectively, reviewed in Ref. 6 , disclosing the mammary cell lineage(s) in which the PR is expressed-and how this expression is hormonally controlled in vivo-is an imperative.
Toward this goal, the lacZ reporter encoding ␤-galactosidase (␤-gal) was knocked into exon 1 of the murine PR gene by gene-targeting approaches to accurately chart the endogenous pattern of PR promoter action in a spatiotemporal context. The ability of this new PR reporter mouse, the PR lacz mouse, to accurately monitor the spatiotemporal regulation of PR promoter activity in the pituitary gland, uterus, and ovary, three classic progestin target tissues, validated the PR lacz mouse as a Abbreviations: aa, Amino acid; E, estrogen; ER, estrogen receptor; ES, embryonic stem; FITC, fluorescein isothiocyanate; ␤-gal, ␤-galactosidase; hCG, human chorionic gonadotropin; neo r , neomycin resistance; P, progesterone; PFA, paraformaldehyde; pgkneobpA, neo r cassette; PMSG, pregnant mare serum gonadotropin; PR, progesterone receptor; PR-A and PR-B, two PR isoforms; PRKO, PR knockout; TEB, terminal end bud; TRITC, tetramethlyrhodamine isothiocyanate; TSA, Tyramide Signal Amplification. legitimate research tool with which to explore the regional, temporal, and hormonal regulation of the PR promoter in the less well characterized, but equally important, P-responsive target tissue-the mammary gland. In addition to recent transgenic models (12, 13) , the PR lacz mouse represents an ideal reporter with which to confirm or explore novel E-and/or P-signaling pathways in situ and portends the expansion of a new subfamily of mouse models in which heterologous genes are expressed under the governance of the PR promoter in vivo. Figure 1A diagrams the knockin strategy to target the insertion of the lacZ reporter into exon 1 of the murine PR gene by homologous recombination. In the design of the targeting vector (Materials and Methods), disruption of presumptive estrogen response elements was avoided (14, 15) . Containing its own start codon and nuclear localization signal, the lacZ reporter was inserted 120 amino acids (aa) downstream of (and in-frame to) the initiating methionine for the PR-B isoform (16); a short region (122 aa) of the N-terminal domain, containing the initiating methionine for the PR-A form, was deleted with this knockin strategy. The positive/negative selection approach was used to enrich for targeted events in embryonic stem (ES) cells (17) ; by Southern analysis, a targeting frequency of approximately 10% was achieved. Using two independent targeted ES cell lines, panel B shows a confirmatory Southern of resultant wild-type, PR lacZ , and PRKO lacZ mouse genotypes derived from one of these cell lines; as for the 5Ј probe (shown in panel B), the 3Ј probe did not reveal aberrant integration events in the clones analyzed (data not shown). The PR lacZ mouse, heterozygous for the lacZ insertion, is a phenocopy of the wild type, whereas the PRKO lacZ mouse, homozygous for the lacZ insertion, is a phenocopy of the previously described PRKO mouse (5); for much of the studies described herein, we have focused our analysis on the PR lacZ mouse. Double immunofluorescence was employed to verify that the PR lacz mouse exhibits cellular coexpression for lacZ and PR. As shown for the mammary gland (Fig. 1C) , primary antibodies to ␤-gal (␤-gal encoded by LacZ) and to PR (as visualized by fluorescein isothiocyanate (FITC) (green) and tetramethlyrhodamine isothiocyanate (TRITC) (red) fluorescence, respectively) clearly showed that LacZ expression colocalized faithfully with endogenous PR expression.
RESULTS

Targeted Insertion of the LacZ Reporter into the Murine PR Gene
Before determining PR promoter regulation in the mammary gland, the PR lacz mouse was tested for its ability to accurately detect PR promoter activity in situ in three previously characterized P-target tissues: the pituitary gland, uterus, and ovary.
The PR lacz Mouse Faithfully Detects PR Promoter Activity in the Pituitary Gland and Uterus
The endocrine phenotypes of the PRKO female highlighted the functional importance of the P-signal in the elicitation of endogenous and E-induced preovulatory gonadotropin surges and underscored the functional importance of pituitary derived (as well as hypothalamic derived) PR-mediated signaling in the normal progression of the ovarian cycle (18) (19) (20) . In Fig. 2A (21, 22) , the primary secretagogue expressing the PR in the anterior pituitary gland is the gonadotrope; however, recent in vitro investigations suggest that lactotropes also express the PR in the murine anterior pituitary gland (23)-a clear distinction from the rat and primate (24) .
Ovariectomy resulted in a significant reduction in PR lacZ expression in the pituitary of the adult female (panel E) as compared with the intact female (panel B), whereas E administration (panel F) reinstated the regional distribution and level of PR lacz expression. This result not only underscored the importance of ovarianderived E in the induction of the PR in the anterior pituitary gland but also demonstrated the fidelity of the 
PR
lacz mouse in tracking P and E modulation of PR promoter activity in vivo. Despite estrogen receptor-␣ (ER-␣) expression in the pituitary of the adult male (25) [panel G, inset (black arrows)], PR lacz expression was not detected; however, PR lacz was induced with exogenous E to levels comparable to those detected in the pituitary of the similarly treated ovariectomized female (panel H). Although the E induction of PR lacz expression in the male pituitary is of uncertain physiological relevance, this observation does serve to showcase the potential utility of the PR lacz mouse as a powerful mouse platform with which to uncover hitherto unsuspected E-and P-signaling pathways in vivo.
Historically, the uterus has represented the archetypal target-tissue for P action; like the pituitary, this tissue has been studied extensively with respect to steroid hormone modulation of PR and ER-␣ expression (26, 27) . Panels I-K show the effect of P or E administration on PR lacZ expression in the epithelial, stromal, and myometrial cellular compartments of the uterus. Significant PR lacZ expression was observed in the luminal and glandular epithelial compartments within the uterus of the untreated ovariectomized mouse (panel I); however, after P administration, this expression was not detectable in all uterine cell types (panel J). In concert with a classic E-induced uterotropic response, E administration resulted in a significant increase in the level of PR lacz expression (panel K). In agreement with recent findings by our group and others (26, 27) , E treatment for 4 d resulted in a downregulation of PR lacz expression in the hyperplastic luminal epithelial cell layer, whereas PR lacZ expression was significantly increased in the glandular and myometrial compartments; PR lacZ expression was also increased in the stromal compartment.
Although PR lacz expression was not detected in the uterine vasculature of the ovariectomized PR lacz mouse (panel L; arrow), PR lacZ expression was clearly observed after E treatment (panel M; arrow) and was restricted to the outer smooth muscle cell layer of the capillary (panels N and O); PR lacz expression was also detected in the uterine vasculature of the intact virgin (data not shown).
PR lacz Expression Is Acutely Induced in Granulosa Cells of the Preovulatory Follicle
Unlike in the pituitary and uterus, intraovarian PR expression is transiently induced in granulosa cells of the preovulatory follicle by LH (reviewed in Ref. 28 ). Because of the distinct regulation of the PR promoter in this tissue, the ovary was included to determine whether this alternative mode of PR promoter regulation could also be shown in the PR lacz mouse. Due to the low level of LH-induced PRs in this tissue (29) , the PRKO lacZ mouse was employed for more sensitive detection (both PR alleles harbor the lacZ knockin mutation in the PRKO lacz mouse); despite a defect in follicular rupture (5), the PRKO ovary develops normally throughout the preovulatory stages and undergoes luteinization. PR lacZ expression was not detected in the ovary of the 21-d-old mouse without hormone treatment (data not shown) nor 48 h after the administration of pregnant mare serum gonadotropin (PMSG) (Fig. 3A) ; PMSG is an analog of FSH. However, as early as 4 h after human chorionic gonadotropin (hCG) treatment, PR lacZ expression was clearly observed in the granulosa cells of preovulatory follicles (panel B) with highest levels of PR lacz expression attained within 8 h of hCG administration (panel C); hCG is equivalent in action to LH. After ovulation (14-16 h after hCG treatment in the mouse) and subsequent luteinization, PR lacZ expression was undetectable in resultant corpora lutea, 24 h after hCG treatment (panel D). Panel E shows a higher magnification of a preovulatory follicle, notice PR lacz expression is restricted to the mural granulosa cells (panel E, blue arrowhead) but is not expressed in the oocyte (panel E, arrow) or the cumulus cells (panel E, black arrowhead), supporting PR's dedicated role in follicular rupture but not necessarily in oocyte viability after ovulation (30) . In the case of the oviduct, PR lacz expression was predominantly localized to the tall columnar epithelial cells (ciliated and nonciliated) that line the oviductal lumen (panel F, gray arrowhead); a small number of smooth muscle cells dispersed within the oviductal wall also expressed PR lacz (panel F, brown arrowhead).
In sum, the spatiotemporal expression profile for PR lacz in the pituitary, uterus, and ovary (three distinct target tissues for P action) endorse the PR lacz mouse as a valid model system with which to further examine PR promoter function in less well-characterized Ptarget tissues, such as the mammary gland.
Distinct Differences in the Level and Spatial Distribution of PR lacZ Expression in the Mammary Gland as the Mouse Develops from Puberty to Sexual Maturity
Whole mount analyses revealed robust PR lacZ expression throughout the epithelial structures within the mammary gland of the peripubertal (5 wk old) mouse (Fig. 4A) ; a similar expression pattern was observed in the neonatal anlagen (data not shown). A conspicuous high level of PR lacZ expression was observed in the multicell-layered terminal end buds (TEBs), transverse and longitudinal sections of which (panels B and C, respectively) demonstrated that PR lacZ expression was exclusively localized to the body cells as well as to the monolayer of luminal epithelial cells that lines the subtending duct; PR lacZ expression was not detected in the cap and myoepithelial cells, periductal fibroblasts, stromal adipocytes, or in the vasculature. After the first number of estrous cycles, the mammary gland of the 8-wk-old or juvenile was shown to exhibit the highest level of PR lacZ expression as compared with all other stages of mammary development; furthermore, most luminal epithelial cells scored positive for PR lacZ activity (panels D-F). Remarkably, in the sexually mature adult mouse (16 wk old) (panels G-I), the level of PR lacZ expression was significantly attenuated and adopted a nonuniform expression pattern as compared with the juvenile female (compare panel I with F). Figure 5 shows a high magnification of mammary sections from the PR lacz juvenile (A), the PRKO lacz adult (B), and the PR lacz adult (C). Based on morphology and ability to express PR lacz , two luminal epithelial cell types were clearly discernible in the mammary gland of the juvenile (A). The first cell type contained large elliptical nuclei and exhibited robust PR promoter activity (blue arrow), whereas the second cell type, which was PR lacz negative, harbored an elongated nucleus and protruded into the ductal lumen (red arrow); in most cases, one to three PR lacz negative cells were interposed between two PR lacz positive cells. Interestingly, examination of the adult PRKO lacz mammary gland (B) revealed a similar PR lacz expression pattern, supporting the postulate that a functional P-signaling pathway is not essential for the de novo development of cells that normally express PR in the juvenile, nor is it required for the establishment of the uniform expression pattern, but it is required for the elaboration of the nonuniform pattern observed in the adult PR lacz mouse (C).
PR Promoter Activity Is Exclusively Associated with a Specific Cell Type in the Mammary Gland
Unlike in the PR lacz juvenile and adult PRKO lacz mammary gland, the PR lacz negative cell population (black arrows) in the mammary gland of the PR 
The PR Promoter Is Distinctly Modulated by E and P in the Mammary Luminal Epithelial Cell
Because the establishment of a uniform cellular pattern for PR lacZ expression in the murine mammary gland coincided with the onset of puberty and because the transition of this expression pattern to a nonuniform pattern in the sexually mature adult corre- lated with the cumulative exposure of the gland to cyclical elevations of E and P during the estrous cycle, the ovariectomized PR lacZ mouse (16 wk old) was treated with E, P, or E ϩ P to evaluate the potential of these hormones to modulate the level and spatial pattern of PR lacZ expression in the luminal epithelial compartment as previously observed in Fig. 4 . As shown in Fig. 6 (A-C) , 2 wk after ovariectomy, PR lacZ expression was markedly abrogated in the mammary gland of the adult female (compare Fig. 6, A-C with Fig. 4, G-I) . Administration of E alone (panels D-F) significantly induced PR lacZ expression to a level that was observed in the intact 8-wk-old juvenile female (Fig. 4,  D-F) ; note also the establishment of a uniform pattern for PR lacZ expression in response to E (Fig. 6F) . Panels G-I demonstrate that P treatment alone does not alter the PR lacZ expression pattern previously observed in the untreated ovariectomized female; compare panels G-I with A-C. However, P, in combination with E was sufficient to reestablish the nonuniform expression pattern for PR lacZ activity normally observed in the adult gland; note the increased tertiary ductal sidebranching and associated alveologenesis in response to the inclusion of P; compare panels J-L with D-F.
PR lacZ Expression in the Embryonic and Male Mammary Gland
Motivated in large part by the significant PR lacZ expression observed in the peripubertal mouse (and neonate; data not shown) as shown in Fig. 6 , we examined whether PR lacZ expression existed in the embryonic mammary gland (Fig. 7, A-C) . Unanticipated was the finding that PR lacZ expression was clearly discernable in the primary lactiferous duct and associated primordial ductal branches within the 16-d-old female embryonic mammary gland (panels A and B; black arrows); note also PR lacZ expression in the submandibular salivary glands (31) (panel A; blue arrow). A further surprise was the detection of PR lacZ expression in the mammary rudiment of the 14-d-old male embryo (panel C; black arrow) and that this expression was also observed in the vestigial epithelial duct of the 16-wk-old adult male mammary gland [panels D (black arrow) and E]. Unlike most mouse strains in which the male mammary epithelial remnant degenerates during embryogenesis (32, 33) , our 129SvEvXC57BL/6 sub-strain joins a small subgroup of mouse strains (34, 35) in which the epithelial remnant in the male gland is not completely destroyed in response to fetal androgens. Moreover, in response to E (panels F-H) or E plus P (panels I and L), this primitive mammary epithelial structure exhibited limited progression from the nipple region to the lymph node; interestingly, in the case of the E-and P-treated gland, limited ductal side branching was observed concomitantly with the presence of TEB-like structures located at the advancing epithelial front (panel K). Again, as with the female, E induced a uniform cellular pattern for PR lacZ expression (panel H), whereas the coadministration of P resulted in a nonuniform cellular organization for PR lacZ expression (panel L); panel K represents a cross-section through a typical TEB-like structure in response to E and P. Figure 8 profiles PR lacZ expression in the inguinal mammary gland during early pregnancy (d 4) (panels A-D); late pregnancy (d 18) (panels E-G); the day of parturition (panel H); lactation (d 7) (panels I-L); and involution (d 7) (panels M-P). A noticeable feature of PR lacZ expression during early pregnancy was its predominant localization to the distal tips of newly formed tertiary side branches (panels B and C; black arrows). During this phase of the mammary cycle, the mammary gland undergoes significant epithelial proliferation; note in panel D, a clear demarcation between those cells that express PR lacZ (blue arrowhead) and those undergoing proliferation (brown arrowhead), supporting the involvement of a complex paracrine circuitry in the mediation of the P-induced proliferative signal during this stage of mammary development. As mammary gland development progressed toward the end of pregnancy and terminal differentiation, the level of PR lacZ expression was significantly reduced, with the majority of PR lacZ positive cells localized to the main ducts (panels F and G; black arrow); at the onset of parturition, PR lacZ expression was not detected (panel H). In the case of the lactating mammary gland, PR lacZ expression was negligible but could be induced by E; as recently shown for the rat (36), the inset in panel K (white arrow) revealed a significant level of ER-␣ expression during this phase of mammary development (ER-␤ expression was not evaluated in this study). During involution, PR lacZ expression was not detected (panels M-O); however, as for the lactating gland, PR lacZ expression was induced by E during this stage of mammary development (panel P).
Progressive Attenuation of PR lacZ Expression as the Mammary Gland Attains Functional Differentiation
Localized PR lacZ Expression to Newly Formed Ductal Side Branches in Response to P
The significant concentration of cells expressing PR lacZ toward the tip of the extending tertiary side . E and P Modulation of PR lacZ Expression in the Mammary Gland A and B, Low and high magnification of whole mounts from a 16-wk-old untreated ovariectomized PR lacZ mouse, respectively; a section of a medial duct reveals negligible PR lacz expression (panel C). After E administration, robust PR lacZ expression is observed in the mammary gland of the ovariectomized PR lacz mouse (panels D and E). Apart from an increase in PR promoter activity per cell; almost every luminal epithelial cell expresses PR lacz with this hormone treatment (panel F). Similar to panels A-C, P administration has no effect on PR lacz expression in the mammary gland of the ovariectomized PR lacz mouse (panels G-I). However, P in combination with E results in extensive ductal branching and alveologenesis (panels J and K); note the nonuniform pattern for PR lacz expression in the main ducts (panel L) and the concentration of cells expressing PR lacz in the newly formed ductal side branches (panel L, inset). Scale bars in panels A and D represent 2 mm; scale bar in panel D applies to whole mounts shown in panels G and J. Scale bar in panel B denotes 0.2 mm and also applies to panels E-K, whereas scale bar in panel C equates to 0.1 mm and applies to panels F-L. branch during early pregnancy (Fig. 8B ) coupled with our previous observation that P can modulate the cellular pattern for PR lacZ expression as the mammary gland progresses from the pubescent to the adult stages of development (Fig. 4) , prompted us to evaluate whether the administration of P alone to the intact adult could recapitulate the branching pattern and cellular organization for PR lacZ expression that occurs during early pregnancy. Figure 9 shows that the administration of P to intact adult females (12 wk old) resulted in an increase in tertiary ductal side branching, but unlike E plus P treatment, did not elicit alveologenesis (panels A-D). Its important to note that to avoid the presence of a significant number of ductal side-branches before hormone administration, the 12-wk-old was used, rather than the 16-wk-old-nulliparous mouse. Importantly, although P caused a downregulation of PR lacZ expression in the main ducts, as observed during early pregnancy; a significant concentration of cells expressing PR lacZ was observed toward the distal portion of P-induced side-branches (Fig. 9, E and F) . 
DISCUSSION
Although the PRKO mouse underscored the functional importance of the PR to female fertility (5), progress in understanding the underlying cellular mechanism(s) by which this transcription factor exerts its physiological effects has been hampered by insufficient information concerning the cell lineages in which the PR is expressed and how this expression is hormonally controlled in situ.
To address this issue, we employed experimental mouse genetics and the lacZ reporter to define the PR's promoter activity in its appropriate physiological context, at both the whole mount and histological level. Rather than using a conventional transgenic approach, the effectiveness of which is dependent upon the inclusion of all regulatory elements of the gene in question and on the site of integration, we adopted a knockin strategy to target the lacZ reporter to the authentic PR locus.
Our initial studies on the pituitary, uterus, and ovary demonstrated the utility of the PR lacZ mouse to unequivocally identify those cell types that express this transcription factor; furthermore, the PR lacZ mouse detected the well recognized induction of PR promoter activity by E and LH as well as its repression by P.
For the majority of the studies presented herein, we have focused on applying the PR lacz mouse to defining the spatiotemporal activity profile of the PR promoter during the prenatal and postnatal stages of mammogenesis, including lactation and involution. In agreement with previous studies (37-39), which used mo- lecular and immunoprobes to PR, the PR lacz mouse demonstrated that PR promoter action is restricted to the epithelial compartment of the mammary gland and specifically to the luminal epithelial cell lineage. Remarkably, although the PRKO mammary phenotype is not manifest until adulthood, the highest levels of PR promoter activity were observed during the embryonic, neonatal, and juvenile stages of mammary gland development. Although the functional significance of this early promoter activity is unknown, this observation supports the emerging hypothesis, shared by our group and others (37, 39) , that early expression of the PR may serve to irrevocably commit a cell toward an alveolar developmental pathway later in mammary development. The existence of PRs in the embryonic male mammary gland would suggest that this developmental process is not selectively imprinted in the female; however, due to the absence of ovarian hormones, this process is not realized in the adult male.
Although the analysis of the PR lacz mammary gland confirmed the exclusivity of the luminal epithelial cell with respect to PR expression, this expression is not static but undergoes marked spatiotemporal changes: first, during the transition from the juvenile to the nulliparous sexually mature adult; and second, during the mammary cycle of pregnancy, lactation, and involution.
Consistent with recent immunofluorescent studies (39) , the PR lacz mouse demonstrated that the cellular distribution for PR promoter action in the mammary gland underwent a striking change from a uniform in the juvenile to a nonuniform pattern in the nulliparous mature adult. Steroid-treated ovariectomized PR lacz mice underscored the importance of ovarian E as the primary hormonal cue for the establishment of the above uniform expression pattern in the juvenile mammary gland, whereas ovarian P was required to generate the nonuniform pattern for PR lacz expression in the gland of the young adult. Because neither apoptosis nor proliferation are prominent features during this stage of mammogenesis (40) , it is more likely that cell-selective down-regulation of the PR promoter is responsible for the establishment of the nonuniform expression pattern for PR. The presence of a nonuniform expression pattern for PR in both the adult human (41) and rodent (39, 42) mammary gland suggests an evolutionary conserved role for this cellular organization in P-induced mammary morphogenesis; the conspicuous absence of this cellular organization in the recently reported CCAAT/enhancer binding protein ␤ knockout mammary gland (39) , in which ovarian steroids fail to elicit epithelial proliferation, would further support this proposal.
During early pregnancy, PR lacz expression was evident throughout the mammary ductal architecture with prominent expression at the distal regions of advancing tertiary side branches. This observation is congruent with recent immunohistochemical studies (43) and supports the notion that the regional concentration of PR positive cells at the growth points of these ducts is particularly important for their extension into the mammary fat pad. As pregnancy progressed toward parturition, the PR lacz mouse clearly showed that PR promoter activity attenuated in the mammary gland, with minimal activity during lactation and involution. Interestingly, administered E could induce a nonuniform PR lacz expression in the periparturient mammary gland, suggesting that PR positive cells in the mammary gland of the prepregnant animal may still exist during this stage of mammary gland development.
Application of the PR lacz mouse to profile PR promoter activity during mammary gland development has highlighted established as well as relatively new questions regarding the role of P as an endocrine mammogen. These questions include: 1) Does early PR expression determine mammary cell fate? 2) Are the dynamic changes in the PR's spatiotemporal expression pattern essential for normal mammary morphogenesis? and 3) What regions of the PR promoter are required for its hormonal regulation during mammary gland development? Possible future experiments to address the first question include the use of the PR lacz mouse in combination with cell-sorting and transplantation approaches to determine whether isolated PR positive cells can generate ductal, alveolar, or both mammary epithelial structures. Our ongoing studies to address the second question include conditional transgenic approaches to spatiotemporally control PR expression in the PRKO mammary gland, whereas the recent isolation of bacterial artificial chromosomes containing the entire PR promoter (44) promise to offer significant advances toward addressing the third question.
Finally, the PR lacz mouse joins an expanding subfamily of mouse models that were designed to query the involvement of P in female reproduction in general and in mammary gland development in particular. Apart from accurately disclosing PR promoter activity in situ and representing a mouse platform with which to explore new E-and P-signaling pathways in the future, the PR lacz mouse validates our knockin strategy as a general genetic approach with which to position other genes, such as CRE recombinase (45) and the reverse tetracycline transactivator (46, 47) , under the precise control of the PR promoter, such future PR knockins will be indispensable to unraveling the molecular mechanisms that underpin PR function in vivo.
MATERIALS AND METHODS
Targeted Insertion of the LacZ Reporter into the Murine PR Gene
A 7-kb genomic DNA fragment (129Sv derived) containing the 5Ј upstream-untranslated region and sequence extending from exon 1 to intron 3 of the murine PR gene (5) (16) . To enable drug selection, the neomycin resistance (neo r ) cassette, pgkneobpA, was cloned immediately 3Ј to the lacZ reporter; the pgkneobpA cassette was previously described (5) . With a concomitant 366-bp deletion of PR sequence, the combined insertion of the lacZ and neo r cassettes into exon 1 of the PR gene segregated the above 7 kb mPR genomic fragment into 5Ј and 3Ј arms of homology that were 1.2 and 5.5 kb in size, respectively. The herpes simplex virus thymidine kinase (MC-1 HSV-TK) gene (17) was cloned 5Ј to the 1.2-kb arm of homology with a transcriptional orientation opposite to both the neo r and mPR genes; the MC-1 HSV-TK was a gift from Dr. Mario R. Capecchi, Howard Hughes Medical Institute Research Laboratories, University of Utah (Salt Lake City, UT). The cloning plasmid used in this vector construction was pSP72 (Promega Biotech, Madison, WI). Before electroporation into mouse ES cells, the PR lacZ targeting vector was linearized at the 3Ј end of the long arm of homology with the restriction enzyme Asp 718.
All ES cell culturing and manipulations before and after the electroporation step were preformed as previously reported (5) . At a cellular concentration of 10 7 cells/ml, ES cells (AB2.2) were electroporated with 25 g of the PR lacZ targeting vector in a volume of 0.9 ml at 230V and 500 F; AB2.2 cells were kindly provided by Dr. Allan Bradley (Baylor College of Medicine, Houston, TX). Using 5Ј and 3Ј DNA probes located just outside the region of homology contained within the targeting vector, correctly targeted ES cells [1-(-2-deoxy-2-flouro-1-␤-D-arabino-furanosyl)-5-iodouracil and G418 resistant] were identified by Southern analysis. Male chimeras obtained from two-targeted ES cell clones were crossed with C57BL/6 mice with resultant germ-line transmission of the lacZ insertion; for the investigations described herein, mice with a mixed 129SvXC57BL/6 background were used.
Staining for ␤-Gal Activity, Double Immunofluorescence, and General Immunohistochemistry
For ␤-gal detection within mammary gland tissue, the inguinal gland (abdominal no. 4) was spread on a glass slide before fixation in chilled 2% paraformaldehyde (PFA), pH 7.4, for 2 h at 4 C; fixed tissue was subsequently thoroughly rinsed in three changes of PBS over a 90-min period. Tissues were then immersed in lacZ staining solution [1.3 mM MgCl 2 , 15 mM NaCl, 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 .3H 2 O, 0.02% Nonidet P-40, 44 mM HEPES (pH 7.9), and 0.05% (wt/vol) 4-chloro-5-bromo-3-indolyl-␤-D-galactopyranoside] at 37 C in the dark, for at least 2 h and up to 16 h depending on the degree of color reaction. After three consecutive 30-min PBS washes, stained mammary tissues were processed for whole mount and/or sectioning; the mammary gland whole mount procedure has previously been documented (5) . For sectioning lacZ stained mammary glands, tissues were serially dehydrated in 70-100% ethanol, postfixed overnight in either Bouin's fixative or 4% PFA, then washed in 70% ethanol, embedded in paraffin and sectioned at 5 m; both whole mounts and sections were lightly counterstained with 0.1% Nuclear Fast Red. Intact embryos were used for whole-mount x-gal staining of mammary glands; for sectioning after staining, embryonic skin overlaying the upper ventral thorax was removed and briefly postfixed in 4% PFA, consecutively washed with PBS and dehydrated with ethanol, before being paraffin-embedded, sectioned at 5 m, and counterstained with Nuclear Fast Red. Sex determination of embryos by PCR amplification of the testis-determining gene, Sry, was performed according to Gubbay et al. (49) .
Although whole pituitaries (and sections thereof) were stained after the procedures above, ovarian tissue (without the fat pad) was embedded in OCT medium (Tissue-Tek, Elkhart, IN), frozen on dry ice, and cryosectioned at 20 m. Ovarian cryosections were fixed for 15 min in 2% formaldehyde, 0.2% glutaraldehyde, 0.02% Nonidet P-40 in PBS, then washed in PBS, and incubated overnight at 37 C in the x-gal staining solution described above; sections were subsequently washed, fixed and counterstained with Nuclear Fast Red.
To confirm colocalization of PR and ␤-gal expression, PR lacZ mammary sections were incubated with a rabbit antihuman PR polyclonal antibody (1:100 dilution; DAKO Corp., Carpinteria, CA) overnight at room temperature. After PBS washes, sections were incubated with biotinylated goat antirabbit IgG (Vector Laboratories, Inc., Burlingame, CA) for 1 h at room temperature before incubating with TRITC-conjugated streptavidin (1:200 dilution; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). After a blocking step with goat antirabbit Fab (1:100 dilution; Jackson ImmunoResearch Laboratories, Inc.), sections were incubated with a rabbit anti-␤-gal polyclonal antibody (1:200; Cortex Biochemicals, San Leandro, CA) overnight at room temperature. Washed sections were incubated with biotinylated goat antirabbit IgG (Vector Laboratories, Inc.) before overlaying with streptavidin horseradish peroxidase [Tyramide Signal Amplification (TSA) Fluorescence Kit, NEL701 Perkin-Elmer Life Sciences (Boston, MA)] for 1 h at room temperature. Horseradish peroxidase was directly visualized by incubating sections with TSA-FITC substrate (1:50 dilution; TSA Fluorescence Kit) for 10 min at room temperature; slides were washed and mounted before microscopic examination. Using a Carl Zeiss (Jena, Germany) Axioplan 2 microscope equipped with epifluorescence and appropriate TRITC and FITC filters, digital images were captured using Metavue Software 4.6r9 (Universal Imaging Inc., Downington, PA); final image processing and assembly were performed using Adobe Photoshop version 6.0 (Adobe Systems, Inc., San Jose, CA).
Immunohistochemical detection of PR and ER expression and 5-bromo-2-deoxyuridine incorporation has been described previously (7, 39, 50) ; for ER immunofluorescence, a rabbit polyclonal antibody raised against aa residues 145-159 of the human ER protein sequence (Geneka, Biotechnology Inc., Montré al, Canada) was employed using approaches reported by Seagroves et al. (39) .
Images were captured using a color chilled 3CCD video camera (C5810, Hamamatsu Corp., Bridgewater, NJ) attached to a Carl Zeiss Axioskop microscope; photomontages were assembled using Adobe Photoshop.
Mice and Hormone Treatments
Mice were maintained in a temperature controlled (22 Ϯ 2 C) room, 12-h light, 12-h dark photocycle and fed rodent chow meal (Purina Mills, Inc., St. Louis, MO) and fresh water, ad libitum.
Pituitary, Uterine, and Ovarian Studies
Pituitary PR lacz promoter activity was induced or suppressed by an overnight exposure to E (1 g) or P (1 mg), respectively. For uterine hormonal stimulation, ovariectomized mice were administered daily E (1 g) and/or P (1 mg) for 4 d described previously (26) ; the superovulation hormonal regimen was employed as reported (5) .
Mammary Gland Studies
Mammary glands were dissected from mice at various stages of mammary gland development: virgin (5, 8, 12 , and 16 wk), pregnancy [d 3 (early) and 18 (late)], day of parturition, lactation (d 7), and involution (d 7); for timed pregnancies, the morning of observing the vaginal plug was designated as d 0.5 of pregnancy. Mammary glands from male mice were taken at 16 wk of age and at embryonic d 14. For experiments described in Figs. 6, 7, and 9, E (1 g) and/or P (1 mg) (in sesame oil) were administered by daily intrascapular sc injections for 10 d, according to procedures reported previously. In the case of the 7-d lactating and involuting mammary gland, PR laz expression was induced by an overnight exposure to E (1 g).
To remove endogenous ovarian steroid hormones, bilateral ovariectomies were performed according to procedures outlined previously and were approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine and were in accordance with the procedures detailed in the Guide for Care and Use of Laboratory Animals (NIH Publication 85-23).
